repertoires directed to some immunodominant gluten peptides have previously been described, but the global immune response to in vivo gluten exposure in CD has not been systematically investigated yet. Here, we characterized signatures associated with gluten directed immune activity and identified gluten-induced T-cell clonotypes from total blood and gut TCR repertoires in an unbiased manner using immunosequencing. CD patient total TCR repertoires showed increased overlap and substantially altered TRBV-gene usage in both blood and gut samples, and increased diversity in the gut during gluten exposure. Using differential abundance analysis, we identified gluten-induced clonotypes in each patient that were composed of a large private and an important public component. Hierarchical
Gluten-specific CD4+ IFNg+ TCRB repertoires are as diverse as total patient PBMC repertoires while patient gut repertoire diversity is increased during active CD. Significant changes in diversity following antigen exposure indicate uneven shift in repertoires, such as mono-, oligo-or poly-clonal expansion, with possible implications in disease development 19, 20 . To evaluate TCR repertoire diversity and avoid possible bias due to differences in sequencing depth, we downsampled all samples to 27077 reads (the size of the second smallest sorted repertoire). For each repertoire, the median of 100 diversity estimates from 100 downsamples was used for analysis. The sorted CD4+ IFNg+ samples did not show any difference in diversity compared to the highly diverse preand post-challenge total patient PBMC repertoires ( Fig. 1 ), suggesting high diversity in the sorted gluten-specific TCR repertoires. CD patient post-challenge total PBMC repertoires showed no change in diversity compared to their pre-challenge repertoires. Interestingly, although not statistically significant, all CD patient gut biopsy repertoires showed increased diversity during active disease, with a median increase in diversity of 6% (range: 1.9-7.9%) in biopsies before commencing GFD compared to biopsies collected one year after commencing GFD (Wilcoxon Signed Rank Test, P = 0.06, Fig. 1 ).
Gluten exposure induces substantial TRBV gene usage perturbation. We found no statistically significant difference in mean TRBV gene usage between all post-versus pre-challenge PBMC repertoires, and between all GFD-treated versus active disease gut biopsy repertoires (measured either from unique sequences to analyze overall TRBV gene usage or from total reads to detect expanding/contracting genes) (Supplementary Figure S2 ). To investigate this further in each individual, we compared TRBV gene usage between the gluten exposed and unexposed repertoires for each subject. When considering unique clonotypes,TRBV5, TRBV6, TRBV7 and TRBV18 family genes were more frequently used in patient total PBMC repertoires after gluten challenge while only TRBV6 showed increased usage in one patient's biopsy repertoire during active CD ( Fig. 2A and B ; for all TRBV-gene results see Supplementary Fig. S3 ). There were no V gene usage differences between unique clonotypes in the sorted and the unsorted repertoires in the two patients CD005 and CD039, from whom we had both sorted and unsorted repertoire data. Importantly, however, substantial TRBV gene usage perturbation was observed when the analysis was performed using total reads ( Fig. 2C and D, Supplementary Figure S3 ). Particularly for the sorted repertoires, strong over-usage of genes was observed in the TRBV18, TRBV19, TRBV29 and TRBV30 families, in addition to those previously reported in TRB6 and TRB7 [9] [10] [11] 15, 16, 21 (Supplementary Figure S3E ). Overall, TRBV gene usage comparison using total reads (representing all T-cells) detected skewed TRBV gene usage in patients due to antigen induced clonal expansion from the available pool of unique clonotypes.
Gluten exposure is associated with increased repertoire overlap between CD patients. To assess the effect of gluten exposure on amino acid clonotype sharing between individuals, we compared the inter-individual repertoire overlap between pairs of gluten unexposed repertoires to that of pairs of gluten exposed repertoires. Patient PBMC samples did not show significant difference in overlap after gluten challenge, despite a marginal increase (Fig. 3A) . In contrast, there was significantly increased overlap among patient gut biopsy repertoires during active disease compared to biopsies taken after one year GFD (Wilcoxon Signed Rank Test, P = 0.01, Fig. 3A ). We also observed increased overlap from the combined comparison of all pairs of patient PBMC and GUT repertoires ( Fig. 3C) , indicating that the gluten induced public clones in blood are at least partly the same as those residing in the gut even in unrelated patients. These results overall suggest that increased repertoire overlap among patients is a feature of the immune response to gluten. On the other hand, Figure 1 . TCR repertoire diversity in gluten exposed CD patients. (a) No difference in repertoire diversity is observed between gluten specific CD4+ IFNg+sorted TCRB repertoires and pre-(day0) or post-challenge (day6) CD patient PBMC repertoires. Gut repertoires show interesting increase in diversity (decrease in clonality) during gluten exposure (Wilcoxon paired Signed Rank test, two-tailed, p = 0.06; paired t-test, twotailed, p = 0.0077. The p-value from the t-test is shown here since the Wilcoxon signed rank test has limitations when applied to small sample size even though it is the main test employed in this study). Repertoire samples were downsampled to 27077 reads 100 times, each time estimating diversity. For each sample, median of the 100 diversity estimates is used for plotting and statistical comparison. Horizontal bars indicate median. (b) The diversity increase in active CD gut repertoires ranged from 1.9 to 7.9% (median: 6%) of the treated gut repertoire diversity in patients.
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Differential abundance (DA) analysis identifies gluten-induced and -specific T-cells.
We applied the first DA analysis approach (described in the Methods section) to identify DA clonotypes in each individual. For the four patient PBMC repertoires, we found a median of 448 enriched (range: 216-465) and 355 de-enriched (range: 226-808) clones following gluten challenge while the two healthy controls had 243 enriched (range: 241-245) and 393 de-enriched (range: 157-628) clonotypes. For the five gut biopsy repertoires, a median of 631 enriched (range: 384-1130) and 941 de-enriched (range: 466-1127) clonotypes were observed during active disease. These results give a putative estimation of the amount of gluten-induced T-cell clonotypes, which we defined as clonotypes showing significant change in clonal size as a result of gluten exposure regardless of their specificity ( Fig. 4 ).
For the two patients (CD005 and CD039) that had sorted and unsorted repertoires, DA clones identified from their sorted repertoires, compared to their unsorted pre-challenge and post-challenge samples, showed low overlap with those detected from the comparison of their unsorted post-challenge versus pre-challenge repertoires ( Supplementary Table S2 and Figure S4 ). Since DA clonotypes identified from sorted CD4+ IFNg+ repertoires are specific to gluten, the low overlap perhaps indicates that the T-cells specific to the 3 immunodominant gluten peptides among in vitro stimulated sorted clones represent only a fraction of all clonotypes enriched after in vivo gluten challenge, the latter including both gluten specific and non-specific T-cells. We also found little overlap in gluten-induced DA clones across patients, despite the increased overlap in patient total repertoires during gluten exposure ( Fig. 3B and Supplementary Figure S4 ).
Given the observation that gluten exposure increased inter-individual repertoire overlap, we applied the second DA analysis approach (see Methods section) and evaluated the differential abundance of 11834 public clonotypes that were observed in at least two different individuals (constituting 4.7% of the total 251259 unique amino acid clonotypes available in all samples). This analysis was performed separately for the CDPBMC (n = 4), HCPBMC (n = 2), and CDGUT (n = 5) repertoires ( Table 2 ). From the resulting public DA clones, only two of the public enriched DA clonotypes (CASSLGDTQYF and CASSFSYEQYF) from patient PBMCs overlapped to those detected from healthy PBMCs, and one (CASSLTWDTEAFF) to those detected from patient gut repertoires (Supplementary Figure S4 ). More than half of the public DA clonotypes were among the recently published 10692 representative public TCRB clonotypes (repPC) 14 , indicating possible clinical utility in maintaining detailed repository of public TCR clonotypes and their specificities. The list of public enriched clonotypes is available in the supplementary dataset 1.
We also investigated the presence of previously reported gluten reactive TCRB CDR3 clonotypes 7, 11, 15 in our public DA clonotypes. We found 4 previously reported clonotypes: CASSLRSTDTQYF, CASSFRSTDTQYF, CASSIRHTDTQYF and CASSLNWDTEAFF among enriched clones in patient PBMCs, and CASSLGYEQYF among enriched clones in patient gut repertoires. We did not find any previously known clonotype in the We further sought to explore the contribution of public clonotypes in the immune response to gluten. Of the gluten-induced DA clonotypes in each individual as determined by approach one, 10% to 15% were also present in our set of public clonotypes, accounting for an average of approximately 40% and 20% of the cells (reads) in the enriched DA clones of the CDPBMC and CDGUT respectively ( Supplementary Table S2 and Figure S9 ). This estimates the amount of public clonotypes involved in gluten response in each individual, and does not necessarily reflect consistency in response behavior of the clonotypes across patients since most of these clonotypes are not detected from the analysis using approach two. Interestingly, compared to the private DA clonotypes of each patient, higher rate of convergent selection (multiple nucleotide clonotypes coding for identical amino acid clonotype) appears to be a feature of these 'public subset' of the DA clonotypes with an increasing trend during gluten exposure (Supplementary Figure S10) . 
Discussion
Over the last few years, the T-cell repertoire of various autoimmune diseases has been analyzed using non-biased targeted deep sequencing approaches. In the present study, we have utilized T-cell repertoire deep sequencing and investigated the immune repertoire in gluten exposed CD patients. We profiled and characterized global immune repertoire features in peripheral blood in patients following a short 3-day gluten exposure, and in the gut during active CD. We also identified and characterized clonotypes that showed clonal expansion (or contraction) during gluten exposure.
In our study, the immune repertoire during gluten exposure was generally diverse in both PBMC and gut. We did not detect an alteration of the high TCR diversity observed in CD patient PBMC repertoires. Gluten-specific peripheral CD4+ IFNg+ TCR repertoires were also similar in diversity to the total unsorted patient PBMC repertoires, suggesting high poly-clonality in the CD4+ T-cell response specific to gluten. Hardy et al. have reported such diversity at the TCR level in a smaller repertoire of CD4+ IFNg+ T-cells specific to the dominant HLA-DQ2.5-glia-α1a/α2 epitope in both children and adult CD patients, with adult patients not showing any more narrowing of the repertoire specific to the epitope compared to that of children despite more exposure to gluten 18 . The high TCR diversity is also consistent with the cross-reactivity of the gluten-specific T-cells, in which T-cells bearing diverse TCRs are directed to specific immuno-dominant gluten peptides and their homologs 5, 18 .
In active CD patient gut biopsies, there was an increase in diversity (by an average of 6%) compared to the treated repertoires after one year, confirming reports that have found higher repertoire diversity in active CD patient biopsies 22 . The increased diversity in the gut reflects the massive increase in mucosal infiltrating T-cells Figure S11) . In general, the immune response associated with gluten exposure appears to involve a diverse set of T-cell clonotypes directed to gluten, and other possible unidentified antigens involved in CD pathology, such as yet to be identified self-antigens and commensal flora, the latter potentially affected by CDPBMC  70  33  4  33  11  33  17  14  14  3  1  1  21   HCPBMC  95  95  5  51  26  36  37  26  24  0  0  0  47   CDGUT  60  30  0  15  8  13  30  15  30  0  1  0  15   Deriched  public  clonotypes   CDPBMC  75  38  3  38  38  16  18  10  17  0  0  0  22   HCPBMC  102  101  4  56  35  36  46  29  31  0  0  0  53   CDGUT  45  0  0  0  0  0  0  0  0  0  0  0  0   Table 2 . Differential abundance analysis results on public clonotypes. + RankProduct(RP) results from approach two in the DA analysis. *Sequential forward feature (SFS) selection applied on the RP output resulting in differentially abundant (DA) clonotypes. gluten influence on microbiota. Chemokines secreted by the inflammatory cells in active CD could also attract "by-stander" T-cells of many other specificities unrelated to gluten to the site of inflammation. Gluten exposure led to substantial perturbation of the V-gene usage in both the PBMC and gut repertoires in each patient, mainly due to proliferative changes of the available unique clonotypes. We observed significant over-usage of genes in various TRBV gene families in one or more patients resulting from clonal expansion. We also observed significant alterations in previously reported TRBV genes that are preferentially selected for specific immuno-dominant gliadin epitopes 7, 10, 11, 16 , such as TRBV07-02 (over-used in all patient PBMC repertoires and two gut repertoires) and TRBV04-02 (over-used in four gut repertoires and two PBMC repertoires). Similar analyses of the unique clonotypes suggested that patient repertoires maintained a V-gene usage profile that remained more or less stable before and after gluten exposure, particularly in the gut, likely an indication of clonal persistence in the available immune repertoire.
Inter-individual repertoire overlap was significantly increased among patients during gluten exposure, particularly in the gut, suggesting that the immune response to gluten is characterized by a public component. The evidence for the increased repertoire overlap was even more pronounced when we combined patient gut and PBMC repertoires and compared them to their treated counterparts. While semi-public response to specific immuno-dominant gluten epitopes have been previously reported 7, 11 , our data shows that increased amino acid repertoire sharing among CD patients can be detected from the total repertoire (across tissues, and after both a short gluten challenge or long-term gluten exposure) and is likely a major feature of the immune response in CD.
We identified hundreds of differentially abundant clonotypes with significantly altered prevalence during gluten exposure from total repertoires of each individual, both in patients and healthy controls. DeWitt et al. 23 showed that DA clonotypes identified in such manner, i.e. by comparing multiple total repertoires of an individual, captured approximately 60% of known antigen-specific CD8+ cells, whose response magnitude is much higher compared to CD4+ T-cells, in a model of acute viral infection. Since our repertoire data contain response signals coming from both CD8 and CD4 T-cell populations, our estimates are only a rough approximation, possibly an upper bound, of the frequency of gluten-induced T-cells. From these results, we observed that the immune reaction to gluten involved a large private component; public clonotypes constituted between 10-15% of the differentially abundant clonotypes and had an increased rate of convergent selection during gluten exposure. The role and significance of the gluten-induced public clonotypes compared to those that are private in CD pathogenesis is unclear. Public clonotypes are generally less complex and more abundant 24 ; TCR sequences that are more likely to be produced in the thymus also pass thymic selection more often 25 , indicating that positive selection of some abundant public clonotypes to the periphery may have a crucial immunological importance. Public clonotypes in mice have been shown to frequently harbor autoimmune specificities 26, 27 . They have been shown to have capacity for cross-reactivity, as well as specificity to self and foreign antigens 28 . Self-reactive T-cells have also been associated with more efficient response to foreign antigens in terms of response rates, clonal expansion size and sensitivity to inflammatory signals 29 . Overall, while public clonotypes are likely crucial for efficient immune response, dysregulation of their functions may lead to aberrant self-immunity.
By examining changes in the prevalence of a selected set of public clonotypes, we identified enriched public clonotypes across CD patients in PBMC and gut repertoires. Only one clonotype was shared between the public enriched DA clonotypes of PBMC and gut, possibly due to the differences in the duration of gluten exposure or in the abundance of various T-cell subsets in each compartment; of note, CD patient gut repertoires are dominated by cytotoxic gluten-independent intestinal intraepithelial lymphocytes (IELs) during active disease 30 
. In patient PBMCs, the amino acid pattern ASS[LF]R[SW][TD][DT][TE][QA]
[YF] with conserved usage of the arginine at the fifth position, generalizing previously reported motif ASSxRxTDTQY, was over-represented in the most proliferative cluster of enriched clonotypes, which also contained clonotypes that were exactly identical to the previously reported gluten specific T-cell clones 10 . The arginine residue in gluten reactive clonotypes has been shown to be very crucial in the immune response 9, 11, 21 . The dominance of such arginine bearing clonotypes is reduced among the public enriched clonotypes of the gut, possibly suggesting that the public clonotypes specific to the highly immunogenic epitopes play an important role mainly in the early response to gluten exposure. This observation of increased arginine bearing clonotypes following gluten exposure is also detectable in total patient PBMC repertoires but not in total gut repertoires, particularly during active disease (Supplementary Figure S12) . With prolonged exposure to gluten, at least in the gut, the prevalence of arginine bearing gluten reactive clonotypes may wane, with patient gut repertoires becoming increasingly more diverse and dominated by infiltrating T-cells with clonotypes directed to other antigens. It is possible that arginine bearing gluten reactive public clonotypes may commit to long term-memory more often, as they likely have strong functional avidity to gluten epitopes evidenced by their strong enrichment 31, 32 . Once gluten tolerance is broken, these T-cells could be among those that trigger the early adaptive response to gluten upon re-exposure.
This study used small number of samples; the PBMC and gut samples were also not from the same patients. Larger number of samples would have allowed a more representative comparison of repertoires, while matched samples would have provided the possibility to track gluten reactive clonotypes in both compartments. In our experimental setup, we mainly wanted to explore the impact of gluten exposure to the total repertoire in-vivo, which also reflects possible reaction driven by T-cell subsets other than T-helper cells (such as regulatory T-cells, and CD8+ T-cells for which the antigen specificity is unknown), although we did not further study their phenotypes. Thus, the gluten-induced clonotypes we found were not necessarily specific to gluten, but could have been due to secondary effects of its ingestion. Therefore, it would be very informative to study in future the complete profile of the interesting public clonotypes identified, such as their full TCRαβ pairing and gene expression patterns using for instance single cell analysis methods. In spite of these limitations, we were able to identify major immunological signatures associated with gluten exposure, identify gluten-induced clonotypes from total patient repertoires, and estimate contributions of private and public clonotypes to the gluten-induced immune response in patients. In summary, gluten exposure appears to elicit diverse reaction at the TCR level particularly in the gut, and in PBMC as evidenced by the high TCR diversity observed in the gluten specific PBMC CD4+ IFNg+ repertoires. Increased repertoire overlap was seen in unrelated patients, and the immune response in general was characterized by a large private and an important public component. Deeper level of repertoire sequencing with large number of samples could enable identification and tracking of disease associated public clonotypes or immunological signatures, with potential applications such as early diagnosis, disease and treatment monitoring, and patient stratification based on factors such as patient HLA-types and clinical symptoms.
Methods
Subjects and study design. The study participants who provided blood or intestinal biopsy material are presented in Table 1 . All subjects were positive for the high-risk CD-associated susceptibility alleles HLA-DQA1*05 and HLA-DQB1*02 encoding HLA-DQ2.5.
In CD subjects, the diagnostic criteria were duodenal villous atrophy accompanied by elevated serum anti-tissue transglutaminase IgA. For the first two experiments, gluten challenges, blood collections, isolation of PBMC and overnight IFN-γ ELISpot were performed according to Anderson et al. 4 and Tye-din et al. 5 . CD subjects on long-term GFD consumed one of wheat bread (4 slices, equivalent to approximately 10 g/d gluten), barley flakes (120 g/d, equivalent to approximately 8 g/d hordein), or rye bread (equivalent to approximately 8 g/d secalin). In addition, two healthy subjects who had excluded food with gluten for 4 weeks completed the same 3-day wheat bread challenge. PBMCs were isolated from blood collected immediately before commencing gluten challenge (day 0) and 3 days after completing gluten challenge (day 6). PBMCs were either cryopreserved or used to measure responses to gluten-derived peptides stimulatory for CD4+ T cells in overnight IFN-γ ELISpot assays. In the first experiment, DNA was extracted from frozen PBMC stocks collected before and after wheat gluten challenge from 4 CD donors with positive IFN-γ ELISpot responses to gluten peptides, and 2 healthy donors, for bulk TCR analysis. In the second experiment, PBMC collected from 8 CD donors 6 days after commencing gluten challenge with wheat (n = 3), barley (n = 2), or rye (n = 3) were thawed, and incubated with a mixture of three immunodominant gluten peptides (for antigen presentation by mainly B-cells) to identify CD4+ T cells secreting IFN-γ (see below for details). TCR analysis was performed on CD4+ IFNg+ cells sorted by flow cytometry. In the third experiment, TCR analysis was performed on DNA isolated from fresh 2nd part duodenal biopsies from 5 additional CD patients at the time of diagnosis during active disease and again after one year GFD treatment.
Ethics. The study design and recruiting of patients were approved by the Ethics Committees of the Pirkanmaa Hospital District, Finland. All subjects gave written informed consent. Relevant guidelines and regulations were followed when performing the experiments.
Isolation of gluten-specific IFNg-producing T cells.
The cryo-preserved PBMC samples were thawed by resuspension into complete RPMI, and re-stimulated, after a resting period of 60 min at 37°C, with a pool of 3 immunodominant gluten peptides (LQPFPQPELPYPQPQ "DQ2.5-glia-α1a & α2", QPFPQPEQPFPWQP "DQ2.5-glia-ω1 & ω2" and PEQPIPEQPQPYPQQ "DQ2.5-hor-3") 5, 33 , each in a final concentration of 100 microgram/ml. After 16 h, cells were resuspended in PBS, and incubated with IFNg catch reagent, followed by staining with PE anti-IFNg detection antibody (IFNg secretion assay kit; Miltenyi Biotech) and FITC anti-CD4 antibody (clone OKT4; Biolegend), according to manufacturer's instructions. IFNg secreting CD4+ T cells were separated by FACS sorting, using a BD Facs Aria II instrument. Cells were also stained for gut-homing marker CCR9 in 6 of the 8 samples, which showed that the selected CD4+ IFNg+ population was enriched with cells expressing CCR9 compared to CD4+ IFNg− cell fraction (84% vs 40%, Supplementary Figure S13 ). DNA was extracted from the sorted cell pellets using a DNA/RNA extraction kit (Qiagen).
DNA extraction and Sequencing. DNA was extracted (AllPrep DNA/RNA Mini Kit, Qiagen) from 2-10 million pelleted and lysed pre-and post-challenge cell samples of 4 wheat challenged and wheat epitope responding patients, as well as from 2 non-responding healthy controls. For gut samples, total DNA was extracted from snap frozen biopsy specimens, obtained at the time of diagnosis of 5 DQ2 + CD patients with untreated, active disease and confirmed mucosal lesions, as well as biopsies of the same 5 patients after 1 year of gluten-free diet (GFD), using QIAamp Mini Kit (Qiagen, Valencia, CA) as described in Wacklin et al. 34 .
DNA samples (1ug per sample) were sent to Adaptive Biotechnologies and were deep sequenced for TCRB CDR3 region (Seattle, USA, www.adaptivebiotech.com; www.immunoseq.com) with their ImmunoSeq assay which employs optimized multiplex PCR to target and amplify the TCR CDR3 region and Illumina for sequencing 35 . For each unique TCRB CDR3 sequence in a sample, the nucleotide and predicted amino acid sequence, the re-arranged V D and J genes, and the number of sequencing reads were determined.
Sequence data and statistical analysis. Productive sequences without frameshift mutations or stop codons, constituting ~ 80% of our repertoires, were used in all subsequent analyses. We employed downsampling, pre-processing, and data normalization procedures appropriate for each analysis as described in the respective sections. All analyses were done in R (https://www.r-project.org/) and graphs were made using R and Prism 6.0 (GraphPad Software, La Jolla California USA, www.graphpad.com).
Repertoire diversity was estimated using the Shannon entropy index normalized by total number of unique amino acid clonotypes, −∑ ⁎ ⁎ C N ( C log2( ))/(log2( ))
where C i is the relative frequency of unique clonotype i in the repertoire, and N is the total number of unique amino acid clonotypes. A normalized entropy value of 1 reflects high diversity while 0 reflects low diversity. The diversity of every sample was estimated as the median of 100 diversity values calculated from 100 downsampling of each sample to 27077 reads (the size of the second smallest sorted repertoire). Diversity comparison between groups was mainly performed using the non-parametric Wilcoxon Signed Rank Test as assumptions for parametric tests could not be established with the small sample size in this study. But, we also used the parametric paired t-test for some of the analysis since Wilcoxon Signed Rank test has limitations for small sample sizes. For both cases, p-values less than 0.05 were considered significant.
TRBV gene usage was compared between groups of gluten exposed/unexposed repertoires and between the two repertoires of each individual, using information obtained from either unique clonotypes or total reads in repertoires. Comparison between groups was performed using Wilcoxon Signed Rank Test (paired or unpaired as appropriate) with Benjamini-Hochberg (BH) adjusted p-values less than 0.05 considered significant. Comparison between different repertoires sampled from an individual was done using fisher's exact test with BH adjusted p-values < 0.05 considered significant.
Inter-individual repertoire overlap was calculated for every possible pair of repertoires at each time point using:
where O is the estimated inter-individual repertoire overlap between the repertoires, c is the number of identical amino acid clonotypes between the TCR repertoires, a is the number of unique amino acid clonotypes in one of the repertoires, and b is the number of unique amino acid clonotypes in the other repertoire.
To avoid possible bias due to differences in sequencing depth, the overlap was estimated as the median of 100 overlap estimates, each calculated after randomly downsampling both repertoires to the total number of sequence reads in the smaller repertoire. The overlap was then compared between groups using Wilcoxon Signed Rank test (paired or unpaired as appropriate) with p-values less than 0.05 considered statistically significant. Differential abundance (DA) of clonotypes between conditions was performed to identify putative gluten-induced clonotypes whose frequencies differed because of gluten exposure. DA was assessed using two approaches: one was used for identification of DA clonotypes in an individual between repertoires sampled at different time points, and another for identification of public DA clonotypes across individuals by comparing groups of gluten exposed and unexposed repertoires. For approach one, we implemented the fisher's exact test based-algorithm used for DA analysis by DeWitt et al. 23 . In brief, amino acid clonotype abundances were compared between repertoires of an individual sampled at different time points using fisher's exact test. We adjusted p-values of the shared clonotypes between the two time points using Benjamini-Hochberg (BH) and considered clonotypes with adjusted p-values less than 0.01 differentially abundant. We divided the set of DA clonotypes resulting from this analysis into enriched and de-enriched sets based on their frequencies in the compared repertoires
In approach two, we used the Rank product 36 combined with sequential forward feature selection (SFS) to identify public DA clonotypes across patients. Briefly, a clonotype abundance (clonotype count frequency) matrix was prepared for public amino acid clonotypes, which we defined as clonotypes seen in at least two different individuals across all repertoire types: namely, CD patient PBMC repertoires (CDPBMC), Healthy control PBMC repertoires (HCPBMC), Sorted sample repertoires (Sorted) and CD patient Gut repertoires (CDGUT). After data normalization, separate two-class rank product analysis was performed using RankProd 37 for the paired CDPBMC (n = 4), HCPBMC (n = 2), and CDGUT (n = 5) samples. RankProd first ranks clonotypes according to their frequency fold change in the two repertoires sampled from each subject. Next, it computes rank product (RP) for each clonotype across subjects (the geometric mean of the ranks for the clonotype across individuals). It is unlikely that a clonotype has a top ranking fold change consistently in all replicate experiments by chance, i.e. clonotypes with smallest RP, that result from consistent top ranking in replicate experiments, are likely to be enriched or de-enriched clonotypes of interest (depending on the ranking order of the fold changes). The method identifies these differentially abundant features using a permutation test, by estimating the probability of the RP happening by chance for each clonotype. We further filtered the list of clonotypes showing enrichment (i.e., have substantially higher frequency) or de-enrichment (i.e., have substantially lower frequency), with RP p-values less than 0.01, using sequential forward feature selection (from the most significant to the least) to reduce possible false positives. In this step, we selected the first n clonotypes with a leave-one-out cross validation 38 error less or equal to 0.25 when used in a random forest classification model for prediction of sample's gluten exposure status. Clonotypes that passed this filter were considered differentially abundant (DA) and were next subjected to cluster analysis. Detailed description of this second approach is available in the supplementary 'Clonal differential abundance analysis procedure' section (see also Supplementary Figure S1 ).
Hierarchical clustering of public DA clonotypes was performed using a modified Levenshtein distance (LD) to estimate pairwise clonotype similarity, by taking into account differences in sequence length and physicochemical properties. The approach combined methods used in previous studies [39] [40] [41] . The physicochemical properties were evaluated using hydrophobicity according to the Kyte and Doolittle scale 42 , acidity according to the isoelectric point(PI) and molecular mass(Da) of the amino acids constituting the CDR3 sequences. For each amino acid clonotype, we used the mean property of the amino acids making up the clonotype to represent the clonotype's overall propensity for that property. Similarity between any two DA clonotypes was then estimated using LD, modified by their difference in length, mean acidity, hydrophobicity, and weight as follows:
Modified LD (LD sequence_lengths mean_Acidity mean_Hydrophobicity mean_Wt)/
(Edit path length)
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The pairwise similarity matrix using this measure was then hierarchically clustered; the dendrogram was cut dynamically 43 and the resulting clusters were assessed for average fold change values. The cluster containing clonotypes with the highest average fold change was considered the 'top cluster' . Clonotypes in the top cluster may be considered the most likely proliferative candidates driving the public component of the immune response to gluten. MEME 44 was used to search for over-represented sequence motifs for clonotypes in each cluster. Data availability. The datasets and R scripts used in the current study are available from the corresponding author on reasonable request.
